🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

BRIEF-Omega Diagnostics Delays Results, Sees FY Adj. Pretax Loss From Cont Ops To Be 0.2 Mln Stg

Published 16/08/2019, 11:06
© Reuters.  BRIEF-Omega Diagnostics Delays Results, Sees FY Adj. Pretax Loss From Cont Ops To Be 0.2 Mln Stg
CNSL
-

Aug 16 (Reuters) - Omega Diagnostics Group PLC ODX.L :

* RE. RESULTS, TRADING UPDATE & NIGERIAN CD4 ORDER

* TRADING IN Q1 OF NEW FINANCIAL YEAR WITH OUR CORE BUSINESS

LINE WITH MANAGEMENT EXPECTATIONS.

* FY TURNOVER EXPECTED TO BE £9.76M (2018: £13.55M),

TURNOVER FROM

CONTINUING OPERATIONS IS EXPECTED TO BE 5% HIGHER AT £8.76M

(2018: £8.33M)

* FY ADJUSTED LOSS BEFORE TAX FROM CONTINUING OPERATIONS IS

EXPECTED TO BE £0.2M (2018: LOSS OF £1.0M).

* DEFERRED RELEASING RESULTS TO GIVE MORE TIME FOR CLARITY

ON SOME

ONGOING COMMERCIAL TALKS, OTHER POST-BALANCE SHEET EVENTS

* GOT PURCHASE ORDER FROM ITS DISTRIBUTOR IN NIGERIA FOR

50,000

UNITS OF ITS VISITECT CD4 350 TEST (ORDER VALUE C. £210K)

Source text for Eikon: ID:nRSP3360Ja

Further company coverage: ODX.L

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.